Clinical Trial Update: Effects of Ferinject® on Anemia and Transfusion Rates After Cardiac Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial updating the effects of Ferinject on anemia and transfusion rates after cardiac surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia Iron-deficiency
• Cardiac Surgery-related Anemia

Drugs mentioned

• Ferinject (ferric carboxymaltose)

Snippet

Sponsor: St Joseph University, Beirut, Lebanon | Conditions: Anemia, Iron Deficiency | Phase 4 | Status: COMPLETED